Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE ETD IND PHARMA
Original Assignee
CENTRE ETD IND PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRE ETD IND PHARMAfiledCriticalCENTRE ETD IND PHARMA
Priority to FR7226161ApriorityCriticalpatent/FR2192814A1/en
Publication of FR2192814A1publicationCriticalpatent/FR2192814A1/en
Application grantedgrantedCritical
Publication of FR2192814B1publicationCriticalpatent/FR2192814B1/fr
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Title cpds. of formula: (where R1 is NH2 or OR where R is 1-4C alkyl; R2 and R3 are H, alkyl or where n = 1-4; R4 and R5 are H or 1-4C alkyl; X and Y are H, NO2, NH2 or halogen), and their acid addn. and quaternary NH4 salts have low toxicity in man and animals. Dosage units of 50-250 mg to a total daily dosage of 50 to 2000 mg may be used in man by oral or rectal administration.
FR7226161A1972-07-201972-07-202-Isopropyl-5-methyl phenoxy acetamides - with peripheral, cerebral and coronary vasodilatory activity
GrantedFR2192814A1
(en)